Viraj Master
Emory University
H-index: 59
North America-United States
Top articles of Viraj Master
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Radiomics at baseline MRI are associated with tumor shrinkage in patients with unresectable renal cell carcinoma treated with neo-adjuvant Cabozantinib | Cancer Research | Liping LI Edouard Nicaise Benjamin Schmeusser Abhishek Midya Amir Davarpanahfakhr | 2024/3/22 |
Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma | CA: A Cancer Journal for Clinicians | Edouard H Nicaise Ahmet Yildirim Swapnil Sheth Ellen Richter Mani A Daneshmand | 2024/4/3 |
MP36-10 UNRAVELING THE “OBESITY PARADOX” IN RENAL CORTICAL TUMORS: INSIGHTS FROM THE INMARC REGISTRY | The Journal of Urology | Cesare Saitta Jonathan A Afari Mimi V Nguyen Kevin Hakimi Dattatraya Patil | 2024/5 |
MP36-07 SHIFTING THE PARADIGM: IMPROVING RENAL CELL CARCINOMA STAGING WITHIN THE AJCC SYSTEM BY ADDING C-REACTIVE PROTEIN-ANALYSIS OF THE INMARC REGISTRY | The Journal of Urology | Cesare Saitta Jonathan A Afari Mimi V Nguyen Kevin Hakimi Dattatraya Patil | 2024/5 |
MP10-16 LINEAR MUSCLE SEGMENTATION FOR METASTATIC RENAL CELL CARCINOMA: CHANGES IN CLINIC-FRIENDLY ESTIMATION PREDICT SURVIVAL IN PATIENTS FOLLOWING CYTOREDUCTIVE NEPHRECTOMY | The Journal of Urology | Edouard H* Nicaise Benjamin N Schmeusser Adil Ali Eric Midenberg Arnold R Palacios | 2024/5 |
PD48-01 EFFICACY OF NADOFARAGENE FIRADENOVEC-VNCG FOR PATIENTS WITH BACILLUS CALMETTE-GUÉRIN-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: FINAL RESULTS FROM A PHASE 3 TRIAL | The Journal of Urology | Stephen A Boorjian Vikram M Narayan Badrinath R Konety Viraj A Master Neal D Shore | 2024/5 |
PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS … | The Journal of Urology | Daniel D Shapiro Jose A Karam Viraj A Master Philippe E Spiess Charles C Peyton | 2024/5 |
2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race | Cancer | Benjamin N Schmeusser Dattatraya H Patil Edouard H Nicaise Manuel Armas‐Phan Reza Nabavizadeh | 2024/2/1 |
Safety and efficacy of surgery in renal cell carcinoma with supradiaphragmatic tumor thrombus involving cardiac procedures. | Edouard Nicaise Yash Shah Benjamin Schmeusser Benjamin Croll Ellen Richter | 2024/2/1 | |
Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches | Divya Chukkalore Kira MacDougall Viraj Master Mehmet Asim Bilen Bassel Nazha | 2024/2/21 | |
IMPACT OF OBESITY ON SURGICALLY-INDUCED RENAL FUNCTIONAL DECLINE FOLLOWING RADICAL AND PARTIAL NEPHRECTOMY: ANALYSIS FROM THE INTERNATIONAL MARKER CONSORTIUM FOR RENAL CANCER … | Urologic Oncology: Seminars and Original Investigations | Jonathan A Afari Cesare Saitta Mimi V Nguyen Kevin Hakimi Luke Wang | 2024/3/1 |
MAYO ADHESIVE PROBABILITY SCORE IS ASSOCIATED WITH WORSE OVERALL SURVIVAL IN PATIENTS UNDERGOING SURGERY FOR CLINICAL STAGE T1 RENAL CELL CARCINOMA | Urologic Oncology: Seminars and Original Investigations | Edouard Nicaise Cameron Futral Sriram Abadi Nahar Imtiaz Dattatraya Patil | 2024/3/1 |
NODESAFE nomogram: A novel score system to predict lymph node involvement at the time of nephrectomy or nodal recurrence in non-metastatic renal cell carcinoma | European Urology | C Saitta C Cerrato J Afari H Tanaka D Patil | 2024/3/1 |
Interruptions in bladder cancer care during the COVID-19 public health emergency | Urologic Oncology: Seminars and Original Investigations | John L Gore Kristin Follmer Jason Reynolds Michael Nash Christopher B Anderson | 2024/4/1 |
MP51-09 COMPARATIVE EFFICACY OF CKD-EPI 2012 AND 2021 EQUATIONS FOR PREDICTION OF SURVIVAL OUTCOMES FOLLOWING RENAL SURGERY: ANALYSIS OF THE INMARC REGISTRY | The Journal of Urology | Margaret F Meagher Maria Mir Viraj Master Riccardo Autorino Andrea Minervini | 2024/5 |
PD18-08 TUMOR SIZE REDUCTION (≥ 10%) RESULTING FROM PRE-SURGICAL SYSTEMIC THERAPY PREDICTS IMPROVED SURVIVAL FOLLOWING CYTOREDUCTIVE NEPHRECTOMY | The Journal of Urology | Daniel D Shapiro Jose A Karam Viraj A Master Philippe E Spiess Charles C Peyton | 2024/5 |
MP44-09 PROGNOSTIC NOMOGRAMS INCORPORATING PREOPERATIVE CRP LEVEL FOR PREDICTING SURVIVAL OUTCOMES IN PATIENTS WITH NONMETASTATIC CLEAR CELL RENAL CELL CARCINOMA: INMARC STUDY | The Journal of Urology | Wei Chen Hajime Tanaka Masaki Kobayashi Shohei Fukuda Akinori Nakayama | 2024/5 |
MP51-14 IS PATHOLOGICAL UPSTAGING TO T3A RENAL CELL CARCINOMA ASSOCIATED WITH A SIMILAR PROGNOSIS TO NON-UPSTAGED PATHOLOGIC T3A DISEASE? A MULTICENTER ANALYSIS | The Journal of Urology | Jonathan Afari Ryan Nasseri Umberto Capitanio Cesare Saitta Riccardo Autorino | 2024/5 |
MP36-17 RENAL FUNCTIONAL IMPROVEMENT AFTER PARTIAL NEPHRECTOMY: PREDICTORS AND CONSEQUENCES | The Journal of Urology | Kit L Yuen Cesare Saitta Yasuhisa Fujii Edouard Nicaise Riccardo Autorino | 2024/5 |
A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila | Genetics | Jovan S Brockett Tad Manalo Hala Zein-Sabatto Jina Lee Junnan Fang | 2024/1/30 |
Co-Authors
